NextCell Pharma AB (OSTO:NXTCL) Total Long-Term Assets : kr21.41 Mil (As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. NextCell Pharma AB's Total Long-Term Assets for the quarter that ended in Feb. 2024 was kr21.41 Mil.

NextCell Pharma AB Total Long-Term Assets Historical Data

The historical data trend for NextCell Pharma AB's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Total Long-Term Assets Chart

NextCell Pharma AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Total Long-Term Assets

Get a 7-Day Free Trial

3.52

3.74

9.15

17.90

21.55

NextCell Pharma AB Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Total Long-Term Assets	Get a 7-Day Free Trial															19.27	21.38	21.55	21.49	21.41

NextCell Pharma AB Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

NextCell Pharma AB Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

NextCell Pharma AB (OSTO:NXTCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

65G:Germany

Address

Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157

Website

http://www.nextcellpharma.com

NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines